BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 8986623)

  • 1. Heparan sulfate proteoglycans play a dual role in regulating fibroblast growth factor-2 mitogenic activity in human breast cancer cells.
    Delehedde M; Deudon E; Boilly B; Hondermarck H
    Exp Cell Res; 1996 Dec; 229(2):398-406. PubMed ID: 8986623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in both heparan sulfate proteoglycans and mitogenic activity of fibroblast growth factor-2 are triggered by inhibitors of proliferation in normal and breast cancer epithelial cells.
    Lambrecht V; Le Bourhis X; Toillon RA; Boilly B; Hondermarck H
    Exp Cell Res; 1998 Dec; 245(2):239-44. PubMed ID: 9851863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of sulfated proteoglycans by human breast cancer cell lines: binding to fibroblast growth factor-2.
    Delehedde M; Deudon E; Boilly B; Hondermarck H
    J Cell Biochem; 1997 Mar; 64(4):605-17. PubMed ID: 9093910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is the sensitivity of cells for FGF-1 and FGF-2 regulated by cell surface heparan sulfate proteoglycans?
    Zhou FY; Owens RT; Hermonen J; Jalkanen M; Höök M
    Eur J Cell Biol; 1997 Jun; 73(2):166-74. PubMed ID: 9208230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro changes in plasma membrane heparan sulfate proteoglycans and in perlecan expression participate in the regulation of fibroblast growth factor 2 mitogenic activity.
    Guillonneau X; Tassin J; Berrou E; Bryckaert M; Courtois Y; Mascarelli F
    J Cell Physiol; 1996 Jan; 166(1):170-87. PubMed ID: 8557766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential regulation of FGF-1 and -2 mitogenic activity is related to their kinetics of binding to heparan sulfate in MDA-MB-231 human breast cancer cells.
    Fernig DG; Chen HL; Rahmoune H; Descamps S; Boilly B; Hondermarck H
    Biochem Biophys Res Commun; 2000 Jan; 267(3):770-6. PubMed ID: 10673367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of heparan sulphate proteoglycans in the regulation of human lactoferrin binding and activity in the MDA-MB-231 breast cancer cell line.
    Damiens E; El Yazidi I; Mazurier J; Elass-Rochard E; Duthille I; Spik G; Boilly-Marer Y
    Eur J Cell Biol; 1998 Dec; 77(4):344-51. PubMed ID: 9930659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acidic and basic fibroblast growth factor bind with differing affinity to the same heparan sulfate proteoglycan on BALB/c 3T3 cells: implications for potentiation of growth factor action by heparin.
    Brown KJ; Hendry IA; Parish CR
    J Cell Biochem; 1995 May; 58(1):6-14. PubMed ID: 7543903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear localization of basic fibroblast growth factor is mediated by heparan sulfate proteoglycans through protein kinase C signaling.
    Hsia E; Richardson TP; Nugent MA
    J Cell Biochem; 2003 Apr; 88(6):1214-25. PubMed ID: 12647303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Involvement of sulfated proteoglycans in the control of proliferation of MCF-7 breast cancer cells].
    Delehedde M; Deudon E; Boilly B; Hondermarck H
    Bull Cancer; 1996 Feb; 83(2):129-34. PubMed ID: 8652906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparan sulfate proteoglycans function as receptors for fibroblast growth factor-2 activation of extracellular signal-regulated kinases 1 and 2.
    Chua CC; Rahimi N; Forsten-Williams K; Nugent MA
    Circ Res; 2004 Feb; 94(3):316-23. PubMed ID: 14684627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of cAMP on E-cadherin expression and cell surface heparan sulfate proteoglycan synthesis in human breast cancer cells.
    Revillion F; Vandewalle B; Hornez L; Lefebvre J
    Anticancer Res; 1993; 13(5A):1625-9. PubMed ID: 8239544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of heparan sulfate in the terminal differentiation of growth plate chondrocytes.
    Chintala SK; Miller RR; McDevitt CA
    Arch Biochem Biophys; 1995 Jan; 316(1):227-34. PubMed ID: 7840621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repression of myogenic differentiation by aFGF, bFGF, and K-FGF is dependent on cellular heparan sulfate.
    Olwin BB; Rapraeger A
    J Cell Biol; 1992 Aug; 118(3):631-9. PubMed ID: 1379245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glypican-1 is overexpressed in human breast cancer and modulates the mitogenic effects of multiple heparin-binding growth factors in breast cancer cells.
    Matsuda K; Maruyama H; Guo F; Kleeff J; Itakura J; Matsumoto Y; Lander AD; Korc M
    Cancer Res; 2001 Jul; 61(14):5562-9. PubMed ID: 11454708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparan sulfate proteoglycans control intracellular processing of bFGF in vascular smooth muscle cells.
    Sperinde GV; Nugent MA
    Biochemistry; 1998 Sep; 37(38):13153-64. PubMed ID: 9748322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular matrix heparan sulfate proteoglycans modulate the mitogenic capacity of acidic fibroblast growth factor.
    Gordon PB; Choi HU; Conn G; Ahmed A; Ehrmann B; Rosenberg L; Hatcher VB
    J Cell Physiol; 1989 Sep; 140(3):584-92. PubMed ID: 2528552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin, but not other proteoglycans potentiates the mitogenic effects of FGF-2 on mesencephalic precursor cells.
    Caldwell MA; Svendsen CN
    Exp Neurol; 1998 Jul; 152(1):1-10. PubMed ID: 9682007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The neural cell adhesion molecule (NCAM) heparin binding domain binds to cell surface heparan sulfate proteoglycans.
    Kallapur SG; Akeson RA
    J Neurosci Res; 1992 Dec; 33(4):538-48. PubMed ID: 1484387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced invasion and tumor growth of fibroblast growth factor 8b-overexpressing MCF-7 human breast cancer cells.
    Ruohola JK; Viitanen TP; Valve EM; Seppänen JA; Loponen NT; Keskitalo JJ; Lakkakorpi PT; Härkönen PL
    Cancer Res; 2001 May; 61(10):4229-37. PubMed ID: 11358849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.